Therefore, our study expands on these findings by suggesting that these N284I, C37R and L360P may also contribute to oncogenic processes in cervical cancer, thereby connecting TLR3 immune dysfunction to tumor biology. The gene discussed is TLR3; the disease is cervical cancer.